Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical bimatoprost with fractional CO2 laser vs bimatoprost alone for alopecia areata
IRCT20210715051895N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bimatoprost in alopecia areata (2 arms), sponsored by Kerman University of Medical Sciences. Started Aug 2021; status: completed.
02
Drugs
bimatoprost
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20210715051895N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210715051895N1.